Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Carfilzomib in Combination With Bendamustine and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

NCT02002598 is registered in ClinicalTrials.gov with Suzanne Lentzsch, MD as lead sponsor.

NCT NCT02002598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02002598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Carfilzomib in Combination With Bendamustine and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Lead sponsor
Suzanne Lentzsch, MD
Phase
Phase 1/2
Overall status
Terminated
Start date
November 30, 2013
Completion date
July 1, 2023
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma